Biotech News
Intellia Therapeutics to Participate in Upcoming Investor Conferences
ir.intelliatx.com2026-05-05 11:34 EST
CAMBRIDGE, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that management will be participating in fireside chats